• Twitter
  • Jobs
ProCURE oncology
  • HOME
  • ABOUT US
  • RESEARCH GROUP
    • Molleví’s Lab
    • Antolin’s Lab
    • Alemany’s & Piulats’s lab
    • Martínez-Balibrea’s Lab
    • Aytes’s Lab
    • Belver’s Lab
    • Pujana’s Lab
    • Menendez’s Lab
    • Sureda’s & Farre’s Lab
    • Casanovas’s Lab
    • Viñals’s lab
  • INNOVATION
  • NEWS
  • CONTACT
  • Menu Menu

Harnessing transcriptional regulation of alternative end-joining to predict cancer treatment

10 de March de 2025
NAR Cancer. 2025 Mar 7;7(1):zcaf007. doi: 10.1093/narcan/zcaf007.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 2025-03-10 10:00:002025-03-10 10:00:00Harnessing transcriptional regulation of alternative end-joining to predict cancer treatment

Mitochondrial priming and response to BH3 mimetics in “one-two punch” senogenic-senolytic strategies

7 de March de 2025
Cell Death Discov. 2025 Mar 7;11(1):91. doi: 10.1038/s41420-025-02379-y.ABSTRACTA…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 2025-03-07 11:00:002025-03-07 11:00:00Mitochondrial priming and response to BH3 mimetics in “one-two punch” senogenic-senolytic strategies

Fatty acid synthase (FASN) inhibition cooperates with BH3 mimetic drugs to overcome resistance to mitochondrial apoptosis in pancreatic cancer

25 de February de 2025
Neoplasia. 2025 Feb 24;62:101143. doi: 10.1016/j.neo.2025.101143.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 2025-02-25 11:00:002025-02-25 11:00:00Fatty acid synthase (FASN) inhibition cooperates with BH3 mimetic drugs to overcome resistance to mitochondrial apoptosis in pancreatic cancer

Lung cancer survival trends and prognostic factors: A 26-year population-based study in Girona Province, Spain

24 de October de 2024
Lung Cancer. 2024 Oct 20;197:107995. doi: 10.1016/j.lungcan.2024.107995.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 2024-10-24 10:00:002024-10-24 10:00:00Lung cancer survival trends and prognostic factors: A 26-year population-based study in Girona Province, Spain

Fatty acid synthase (FASN) is a tumor-cell-intrinsic metabolic checkpoint restricting T-cell immunity

30 de September de 2024
Cell Death Discov. 2024 Sep 30;10(1):417. doi: 10.1038/s41420-024-02184-z.ABSTRACTFatty…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 2024-09-30 10:00:002024-09-30 10:00:00Fatty acid synthase (FASN) is a tumor-cell-intrinsic metabolic checkpoint restricting T-cell immunity

A theory of brain-computer interface learning via low-dimensional control

7 de May de 2024
bioRxiv [Preprint]. 2024 Apr 22:2024.04.18.589952. doi: 10.1101/2024.04.18.589952.ABSTRACTA…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 2024-05-07 10:00:002024-05-07 10:00:00A theory of brain-computer interface learning via low-dimensional control

Silibinin is a suppressor of the metastasis-promoting transcription factor ID3

14 de March de 2024
Phytomedicine. 2024 Mar 6;128:155493. doi: 10.1016/j.phymed.2024.155493.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 2024-03-14 10:00:002024-03-14 10:00:00Silibinin is a suppressor of the metastasis-promoting transcription factor ID3

The Fatty Acid Synthase (FASN) signalome: A molecular guide for precision oncology

30 de December de 2023
Mol Oncol. 2023 Dec 29. doi: 10.1002/1878-0261.13582. Online…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 2023-12-30 11:00:002023-12-30 11:00:00The Fatty Acid Synthase (FASN) signalome: A molecular guide for precision oncology

Metabolic adaptations in severe obesity: Insights from circulating oxylipins before and after weight loss

15 de December de 2023
Clin Nutr. 2023 Dec 6;43(1):246-258. doi: 10.1016/j.clnu.2023.12.002.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 2023-12-15 11:00:002023-12-15 11:00:00Metabolic adaptations in severe obesity: Insights from circulating oxylipins before and after weight loss

Addendum: Immune-related adverse events and atypical radiological response with checkpoint inhibitor immunotherapy in an elderly patient with high PD-L1 expressing lung adenocarcinoma

3 de July de 2023
Oncotarget. 2023 Jul 1;14:668. doi: 10.18632/oncotarget.28471.NO…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2023-07-03 10:00:002023-07-03 10:00:00Addendum: Immune-related adverse events and atypical radiological response with checkpoint inhibitor immunotherapy in an elderly patient with high PD-L1 expressing lung adenocarcinoma

Reduced Graphene Oxide Aerogels Cartridges for Solid Phase Extraction of Benzotriazoles

29 de March de 2023
Materials (Basel). 2023 Mar 22;16(6):2519. doi: 10.3390/ma16062519.ABSTRACTUV-benzotriazoles…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2023-03-29 10:00:002023-03-29 10:00:00Reduced Graphene Oxide Aerogels Cartridges for Solid Phase Extraction of Benzotriazoles

A robust role for motor cortex

27 de February de 2023
Front Neurosci. 2023 Feb 10;17:971980. doi: 10.3389/fnins.2023.971980.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2023-02-27 11:00:002023-02-27 11:00:00A robust role for motor cortex
Page 2 of 11‹1234›»

Filter by categories

  • Alemany’s & Piulats’s lab (131)
  • Antolin's lab (36)
  • Aytes's Lab (24)
  • Belver's Lab (25)
  • Casanovas's Lab (77)
  • Martínez-Balibrea's Lab (43)
  • Menendez's Lab (121)
  • Molleví's Lab (35)
  • Pujana's Lab (110)
  • Sureda's & Farre's Lab (259)
  • Viñals's lab (111)

Twitter

Tweets by ProcureICO
Program Against Cancer Therapeutic Resistance

CONTACT US

Campus IDIBELL
(L’Hospitalet del Llobregat)
Hospital Duran i Reynals, Gran Via 199,
L’Hospitalet del Llobregat,
Barcelona 08908
Tel. +34 93 260 7952

Campus IGTP-IJC
(Badalona)
Campus Can Ruti – IGTP – Building Muntanya,
Rd. Can Ruti, Camí de les escoles s/n,
Badalona, Barcelona 08916
Tel. +34 93 554 3069

Campus IDIBGI
(Girona)
Parc Hospitalari Martí i Julià de Salt, Dr. Castany s/n,
Salt, Girona 17190
Tel. +34 872 987 087

© Copyright - Edisenius
  • Privacy Policy
  • Cookie Policy
  • Legal Notice
Scroll to top
Manage cookie consent
To offer the best experiences, we use technologies such as cookies to store and/or access device information. Consent to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Failure to consent, or withdrawal of consent, may adversely affect certain features and functions.
Functional Always active
Storage or technical access is strictly necessary for the legitimate purpose of allowing the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. Storage or technical access that is used exclusively for anonymous statistical purposes. Without a requirement, voluntary compliance by your Internet service provider, or additional records from a third party, information stored or retrieved solely for this purpose cannot be used to identify you.
Marketing
Storage or technical access is necessary to create user profiles to send advertising, or to track the user on a website or several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
See preferences
{title} {title} {title}